Lack of Evidence of Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure and Reduced Ejection Fraction Discharged on Spironolactone

BACKGROUND: Therapy with evidence-based heart failure (HF) medications has been shown to be associated with lower risk of 30-day all-cause readmission in patients with HF and reduced ejection fraction (HFrEF). METHODS: We examined the association of aldosterone antagonist use with 30-day all-cause r...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Cardiol
Autori principali: Lam, Phillip H., Dooley, Daniel J., Inampudi, Chakradhari, Arundel, Cherinne, Fonarow, Gregg C., Butler, Javed, Wu, Wen-Chih, Blackman, Marc R., Anker, Markus S., Deedwania, Prakash, White, Michel, Prabhu, Sumanth D., Morgan, Charity J., Love, Thomas E., Aronow, Wilbert S., Allman, Richard M., Ahmed, Ali
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5286461/
https://ncbi.nlm.nih.gov/pubmed/27866868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcard.2016.11.006
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi